Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:KBLM

KBL Merger Corp. IV (KBLM) Stock Price, News & Analysis

About KBL Merger Corp. IV Stock (NASDAQ:KBLM)

Advanced Chart

Key Stats

Today's Range
$1.00
$1.05
50-Day Range
$2.15
$11.04
52-Week Range
$4.60
$11.50
Volume
17,942 shs
Average Volume
17,547 shs
Market Capitalization
$5.51 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

KBL Merger Corp. IV is a private equity firm specializing in acquisition, buyout, PIPES and secondaries investments. The firm seeks to invest in healthcare or the healthcare-related wellness industry. In healthcare services the firm seeks to invest in outpatient care, physician practices, behavioral health and payor services. In pharma services the firm seeks to invest in outsourced services, contract research and generics / OTC. In health IT the firm seeks to invest in EMR / HER, revnue cycle management, telemedicine and care management. In minimal reimbursement risk the firm focuses on retail healthcare, wellness and preventative care. In devices and diagnostics the firm focuses on medical devices, diagnostics, genetic testing and lab tools. The firm typically invests in firms located in the United States. The firm seeks to invest in firms with valuation between $200 million to $700 million and EBITDA between $20 million to $70 million. The firms invest in firms with enterprise value $200 million to $700 million. The firm seeks to take majority stakes. KBL Merger Corp. IV was founded in 2016 and is New York, New York with an additional office in Newark, Delaware.

Receive KBLM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for KBL Merger Corp. IV and its competitors with MarketBeat's FREE daily newsletter.

KBLM Stock News Headlines

TBMCR Trailblazer Merger Corporation I RT
PT Kabelindo Murni Tbk (KBLM.JK)
"I'm risking my reputation on this"
Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.
Blue Ridge Bankshares, Inc. Announces Third Quarter 2023 Results
See More Headlines

KBLM Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that KBL Merger Corp. IV investors own include M&T Bank (MTB), AbbVie (ABBV), Algonquin Power & Utilities (AQN), BCE (BCE), Blackrock Resources & Commodities Strategy Trust (BCX), Franklin Resources (BEN) and BlackRock Enhanced International Dividend Trust (BGY).

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
Holding & Other Investment Offices
Sub-Industry
N/A
Current Symbol
NASDAQ:KBLM
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$90 thousand
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$1.12 per share
Price / Book
0.92

Miscellaneous

Free Float
N/A
Market Cap
$5.51 million
Optionable
Not Optionable
Beta
0.17
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (NASDAQ:KBLM) was last updated on 6/1/2025 by MarketBeat.com Staff
From Our Partners